1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Dyslipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, K; Ishida, T; Miyamoto-Sasaki, M; Monguchi, T; Mori, K; Nakajima, H; Toh, R; Yasuda, T | 1 |
| Andrade, JM; Arifa, RD; de Menezes, GB; de Oliveira, MC; de Paula, TP; de Souza, Dda G; Ferreira, AV; Menezes-Garcia, Z; Santos, SH; Teixeira, MM | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Dyslipidemias
| Article | Year |
|---|---|
Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Antioxidants; Aryldialkylphosphatase; Atherosclerosis; Cholesterol; Cholesterol, HDL; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Activating Factor; Polyethylene Glycols; Quinolines | 2013 |
Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet.
Topics: Animals; Cholesterol; Dietary Carbohydrates; Dyslipidemias; Food Handling; Lipid Metabolism; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Mice, Inbred BALB C; Mice, Knockout; Neutrophil Infiltration; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Time Factors; Triglycerides | 2015 |